Salik Ophta SRL

Salik Ophta reported revenue of 0 € for the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).

By total assets for 2025, Salik Ophta ranks among the 2,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 1019.837.016 · VAT BE1019837016
1640 Sint-Genesius-Rode
active in Medical specialists activities (NACE 86220)
operating since 11 Feb 2025 (≈ 1 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Salik Ophta shows with a free account.

See the score
Profile
SRL since 2025
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue0 €
Net result636,464 €
Equity638,464 €
Cash134,702 €
EBITDA934,774 €
Total assets€1.35m
The line marks its sector median: 72.1% (8874 companies).

Accounts of the company itself (not consolidated).

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Salik Ophta's annual accounts

2025
Revenue0 €
Net result636,464 €
Equity638,464 €
Cash134,702 €
EBITDA934,774 €
Total assets€1.35m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 30 Jun 2026

Salik Ophta's financial analysis

Management and control of Salik Ophta

1 active director(s) in the register.

Salik Ophta's shareholders and holdings →

Salik Ophta's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
1019.837.016
VAT number
BE1019837016
Peppol
Registered · 0208:1019837016 · as of 10 Nov 2026
Legal form
SRL
Incorporated
11 Feb 2025
Registered office
1640 Sint-Genesius-Rode
Latest accounts
2025 · filed on 30 Jun 2026
Activity
Medical specialists activities (NACE 86220)

Salik Ophta (SRL) has been based in Sint-Genesius-Rode since 2025, active in: medical specialists activities. For 2025, it reports revenue of 0 €, a net profit of 636,464 € and equity of 638,464 €. Its solvency stands at 47.4%, below the median of its sector (72.1%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Salik Ophta

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Salik Ophta

What is the revenue of Salik Ophta?

According to the 2025 annual accounts filed with the NBB, the revenue of Salik Ophta amounts to 0 €.

What is the VAT number of Salik Ophta?

In Belgium, the VAT number is the company number prefixed with BE: BE1019837016 for Salik Ophta, if the company is VAT-registered. Its company number (CBE) is 1019.837.016.

Where is the registered office of Salik Ophta?

According to the CBE register, the registered office of Salik Ophta is in 1640 Sint-Genesius-Rode.

What is the equity of Salik Ophta?

At the close of the 2025 financial year, the equity of Salik Ophta amounts to 638,464 €, a solvency of 47.4% of total assets.

Who manages Salik Ophta?

The register lists 1 active mandates at Salik Ophta. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Salik Ophta within its sector?

By total assets for 2025, Salik Ophta ranks among the 2,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.

Idonis

The full file of Salik Ophta

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 22 Sep 2026

No credit card, no commitment.

What each plan unlocks →